STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Revenue | 313.90M | 341.22M | 332.94M | 326.24M | 322.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 313.90M | 341.22M | 332.94M | 326.24M | 322.42M |
| Cost of Revenue | 74.32M | 72.57M | 69.13M | 70.12M | 69.76M |
| Gross Profit | 239.58M | 268.66M | 263.81M | 256.12M | 252.65M |
| SG&A Expenses | 197.96M | 188.50M | 186.09M | 184.01M | 178.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 326.25M | 313.87M | 304.99M | 301.60M | 292.71M |
| Operating Income | -12.35M | 27.36M | 27.95M | 24.64M | 29.71M |
| Income Before Tax | -9.05M | 35.02M | 28.61M | 26.77M | 33.70M |
| Income Tax Expenses | 11.16M | 13.25M | 12.00M | 11.47M | 12.35M |
| Earnings from Continuing Operations | -20.21 | 21.78 | 16.61 | 15.30 | 21.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.21M | 21.78M | 16.61M | 15.30M | 21.35M |
| EBIT | -12.35M | 27.36M | 27.95M | 24.64M | 29.71M |
| EBITDA | -5.46M | 33.09M | 33.27M | 29.88M | 34.83M |
| EPS Basic | -0.41 | 0.44 | 0.34 | 0.31 | 0.44 |
| Normalized Basic EPS | -0.11 | 0.46 | 0.38 | 0.36 | 0.45 |
| EPS Diluted | -0.41 | 0.44 | 0.34 | 0.31 | 0.43 |
| Normalized Diluted EPS | -0.12 | 0.46 | 0.38 | 0.36 | 0.44 |
| Average Basic Shares Outstanding | 196.50M | 196.05M | 195.46M | 194.75M | 194.09M |
| Average Diluted Shares Outstanding | 197.72M | 197.69M | 197.33M | 197.04M | 197.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |